Literature DB >> 24293135

Fascinating interaction between host and pathogen.

Y K Amdekar1.   

Abstract

Clinical manifestations of disease depend upon host's immune response that is induced by pathogen and modified by the host's innate and adaptive immunity. Immunocompetent children of similar age and nutrition evoke different responses to the same pathogen varying from benign to potentially fatal condition. This results in diverse clinical presentations of a disease, that is different from the standard expected pattern and thus, poses a diagnostic challenge. Even, subsequent progression of a disease is also variable. It is the balance between immune stimulation, immune suppression and immune tolerance that decides the outcome. In case of balanced response, child recovers completely without any damage. However at times, cure is at the expense of permanent sequalae while in case of unfavourable immune response, survival may not be certain inspite of successful therapy. Symptoms and physical signs of primary disease often overlap with those caused by host's immune response. In such a situation, it is difficult to decide whether therapy of primary disease has failed due to drug resistance or whether persistence or deterioration is the result of immune response. Occasionally pathogen can transform into "superantigen" that may lead to "cytokine storm". Resulting immune-mediated complications may endanger life and at best, treated symptomatically. Immune suppressive drugs such as steroids, chemotherapeutic agents, IVIG or specific antibodies may not be able to suppress undesirable immune response. It is not just the immune suppression that is required but ideally immune modulation. Immune modulation refers to enhancing protective responses while avoiding destructive ones. At present, science falls short of anticipating harmful immune responses and lacks specific immune intervention.Laboratory test results are also dependent on host response and hence need cautious interpretation based on clinical profile in consideration with multiple variables. In final analysis, fight between host and pathogen is a complex one and often unpredictable. It is hoped that most children evoke favourable response but pediatrician has to be watchful even in the most benign disease.

Entities:  

Mesh:

Year:  2013        PMID: 24293135     DOI: 10.1007/s12098-013-1296-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  28 in total

Review 1.  The role of the complement system in innate immunity.

Authors:  Horea Rus; Cornelia Cudrici; Florin Niculescu
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Helper T cell-regulated B cell immunity.

Authors:  L J McHeyzer-Williams; L P Malherbe; M G McHeyzer-Williams
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 3.  The evolution of adaptive immunity.

Authors:  Zeev Pancer; Max D Cooper
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 4.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 5.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

Review 6.  Malaria and anemia.

Authors:  Håkan Ekvall
Journal:  Curr Opin Hematol       Date:  2003-03       Impact factor: 3.284

Review 7.  T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings.

Authors:  Keertan Dheda; Richard van Zyl Smit; Motasim Badri; Madhukar Pai
Journal:  Curr Opin Pulm Med       Date:  2009-05       Impact factor: 3.155

Review 8.  Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update.

Authors:  Stanford T Shulman
Journal:  Curr Opin Pediatr       Date:  2009-02       Impact factor: 2.856

9.  Immunological characteristics of hyperreactive malarial splenomegaly syndrome in sudanese patients.

Authors:  Tayseer Alkadarou; Ahmed Musa; Abedelgader Alkadarou; Mohamed S Mahfouz; Marita Troye-Blomberg; Ahmed M Elhassan; Ibrahim M Elhassan
Journal:  J Trop Med       Date:  2013-03-05

10.  Hyper-reactive malarial splenomegaly: rare cause of pyrexia of unknown origin.

Authors:  Sanjay Verma; Anju Aggarwal
Journal:  Indian J Pediatr       Date:  2007-04       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.